Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes

Abstract Background Glioblastoma (GBM) has one of the worst 5-year survival rates of all cancers. While genomic studies of the disease have been performed, alterations in the non-coding regulatory regions of GBM have largely remained unexplored. We apply whole-genome sequencing (WGS) to identify non...

Full description

Bibliographic Details
Main Authors: Sharadha Sakthikumar, Ananya Roy, Lulu Haseeb, Mats E. Pettersson, Elisabeth Sundström, Voichita D. Marinescu, Kerstin Lindblad-Toh, Karin Forsberg-Nilsson
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Genome Biology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13059-020-02035-x
_version_ 1828292134144311296
author Sharadha Sakthikumar
Ananya Roy
Lulu Haseeb
Mats E. Pettersson
Elisabeth Sundström
Voichita D. Marinescu
Kerstin Lindblad-Toh
Karin Forsberg-Nilsson
author_facet Sharadha Sakthikumar
Ananya Roy
Lulu Haseeb
Mats E. Pettersson
Elisabeth Sundström
Voichita D. Marinescu
Kerstin Lindblad-Toh
Karin Forsberg-Nilsson
author_sort Sharadha Sakthikumar
collection DOAJ
description Abstract Background Glioblastoma (GBM) has one of the worst 5-year survival rates of all cancers. While genomic studies of the disease have been performed, alterations in the non-coding regulatory regions of GBM have largely remained unexplored. We apply whole-genome sequencing (WGS) to identify non-coding mutations, with regulatory potential in GBM, under the hypothesis that regions of evolutionary constraint are likely to be functional, and somatic mutations are likely more damaging than in unconstrained regions. Results We validate our GBM cohort, finding similar copy number aberrations and mutated genes based on coding mutations as previous studies. Performing analysis on non-coding constraint mutations and their position relative to nearby genes, we find a significant enrichment of non-coding constraint mutations in the neighborhood of 78 genes that have previously been implicated in GBM. Among them, SEMA3C and DYNC1I1 show the highest frequencies of alterations, with multiple mutations overlapping transcription factor binding sites. We find that a non-coding constraint mutation in the SEMA3C promoter reduces the DNA binding capacity of the region. We also identify 1776 other genes enriched for non-coding constraint mutations with likely regulatory potential, providing additional candidate GBM genes. The mutations in the top four genes, DLX5, DLX6, FOXA1, and ISL1, are distributed over promoters, UTRs, and multiple transcription factor binding sites. Conclusions These results suggest that non-coding constraint mutations could play an essential role in GBM, underscoring the need to connect non-coding genomic variation to biological function and disease pathology.
first_indexed 2024-04-13T11:02:33Z
format Article
id doaj.art-bace325326104f708a9d8e09bc2fb81c
institution Directory Open Access Journal
issn 1474-760X
language English
last_indexed 2024-04-13T11:02:33Z
publishDate 2020-06-01
publisher BMC
record_format Article
series Genome Biology
spelling doaj.art-bace325326104f708a9d8e09bc2fb81c2022-12-22T02:49:21ZengBMCGenome Biology1474-760X2020-06-0121112210.1186/s13059-020-02035-xWhole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genesSharadha Sakthikumar0Ananya Roy1Lulu Haseeb2Mats E. Pettersson3Elisabeth Sundström4Voichita D. Marinescu5Kerstin Lindblad-Toh6Karin Forsberg-Nilsson7Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala UniversityDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala UniversityDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala UniversityDepartment of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala UniversityDepartment of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala UniversityDepartment of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala UniversityDepartment of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala UniversityDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala UniversityAbstract Background Glioblastoma (GBM) has one of the worst 5-year survival rates of all cancers. While genomic studies of the disease have been performed, alterations in the non-coding regulatory regions of GBM have largely remained unexplored. We apply whole-genome sequencing (WGS) to identify non-coding mutations, with regulatory potential in GBM, under the hypothesis that regions of evolutionary constraint are likely to be functional, and somatic mutations are likely more damaging than in unconstrained regions. Results We validate our GBM cohort, finding similar copy number aberrations and mutated genes based on coding mutations as previous studies. Performing analysis on non-coding constraint mutations and their position relative to nearby genes, we find a significant enrichment of non-coding constraint mutations in the neighborhood of 78 genes that have previously been implicated in GBM. Among them, SEMA3C and DYNC1I1 show the highest frequencies of alterations, with multiple mutations overlapping transcription factor binding sites. We find that a non-coding constraint mutation in the SEMA3C promoter reduces the DNA binding capacity of the region. We also identify 1776 other genes enriched for non-coding constraint mutations with likely regulatory potential, providing additional candidate GBM genes. The mutations in the top four genes, DLX5, DLX6, FOXA1, and ISL1, are distributed over promoters, UTRs, and multiple transcription factor binding sites. Conclusions These results suggest that non-coding constraint mutations could play an essential role in GBM, underscoring the need to connect non-coding genomic variation to biological function and disease pathology.http://link.springer.com/article/10.1186/s13059-020-02035-xGlioblastomaCancerNon-coding constraintGene regulation
spellingShingle Sharadha Sakthikumar
Ananya Roy
Lulu Haseeb
Mats E. Pettersson
Elisabeth Sundström
Voichita D. Marinescu
Kerstin Lindblad-Toh
Karin Forsberg-Nilsson
Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
Genome Biology
Glioblastoma
Cancer
Non-coding constraint
Gene regulation
title Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
title_full Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
title_fullStr Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
title_full_unstemmed Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
title_short Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
title_sort whole genome sequencing of glioblastoma reveals enrichment of non coding constraint mutations in known and novel genes
topic Glioblastoma
Cancer
Non-coding constraint
Gene regulation
url http://link.springer.com/article/10.1186/s13059-020-02035-x
work_keys_str_mv AT sharadhasakthikumar wholegenomesequencingofglioblastomarevealsenrichmentofnoncodingconstraintmutationsinknownandnovelgenes
AT ananyaroy wholegenomesequencingofglioblastomarevealsenrichmentofnoncodingconstraintmutationsinknownandnovelgenes
AT luluhaseeb wholegenomesequencingofglioblastomarevealsenrichmentofnoncodingconstraintmutationsinknownandnovelgenes
AT matsepettersson wholegenomesequencingofglioblastomarevealsenrichmentofnoncodingconstraintmutationsinknownandnovelgenes
AT elisabethsundstrom wholegenomesequencingofglioblastomarevealsenrichmentofnoncodingconstraintmutationsinknownandnovelgenes
AT voichitadmarinescu wholegenomesequencingofglioblastomarevealsenrichmentofnoncodingconstraintmutationsinknownandnovelgenes
AT kerstinlindbladtoh wholegenomesequencingofglioblastomarevealsenrichmentofnoncodingconstraintmutationsinknownandnovelgenes
AT karinforsbergnilsson wholegenomesequencingofglioblastomarevealsenrichmentofnoncodingconstraintmutationsinknownandnovelgenes